- Assistant Professor, Global Health
University of Washington
Seattle, WA 98195
Select from the following:
Dr. Herbeck is an infectious disease epidemiologist who uses genetic analysis and mathematical modeling to answer questions about pathogen transmission and evolution. He received his B.S. from Tufts University and Ph.D. from the University of California, Berkeley.
- PhD (University of California (Berkeley))
- BS (Tufts University)
- Disease Surveillance
- Drug and Vaccine Development
- HIV Transmission
- Host-pathogen Interactions
- Infectious Diseases
- CFAR: Retrovirology and Molecular Data Science Core
- Epidemiological and evolutionary modeling of HIV virulence
- Integrated bio-social models for HIV epidemiology
- Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
- Modeling the Evolutionary and Public Health Impacts of HIV Adaptation in Response to Vaccination
- Molecular epidemiology of HIV and HCV transmission among PWID in Nairobi, Kenya
- Molecular epidemiology of HIV transmission in Seattle
Herbeck J.T., Peebles K., Edlefsen P.T., Rolland M., Murphy J.T., Gottlieb G.S., Abernethy N., Mullins J.I., Mittler J.E., and Goodreau S.M. HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. 2018. Vaccine, 36(4):514-520.
Herbeck J.T., Mittler J.E., Gottlieb G.S., Goodreau S., Murphy J.T., Cori A., Pickles M., and C. Fraser. Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study. 2016. Virus Evolution, 2(2);vew028.
Dennis A.M, Herbeck J.T. (co-first author), Leigh Brown A., Kellam P., de Oliveira T., Pillay D., Fraser C., and M.S. Cohen. Phylogenetic studies of transmission dynamics in generalized HIV epidemics: An essential tool where the burden is greatest? 2014. J AIDS, Jun 24.
Herbeck J.T., Müller V., Maust B.S., Ledergerber B., Torti C., Di Giambenedetto S., Gras L., Günthard H.F., Jacobson L.P., Mullins J.I., and G.S. Gottlieb. Is the virulence of HIV changing? A statistical meta-analysis of trends in prognostic markers of disease progression. 2012. AIDS, 26: 193-205.
Herbeck J.T., Rolland M., Liu Y., McLaughlin S., McNevin J., Zhao H., Wong K., Stoddard J.N., Raugi D., Sorensen S., Genowati I., Birditt B., McKay A., Diem K., Maust B.S., Deng W., Collier A.C., Stekler J.D., McElrath M.J., and J.I. Mullins. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. 2011. Journal of Virology, 85: 7523-34.